by Antonio R. Chaves
American Thinker
For months, bloggers on the fringe of alternative media have been characterizing COVID-19 and its aftermath as a “plandemic” that had been planned out during two pandemic simulations: SPARS in 2017 and Event 201 in 2019. These conferences were supposedly organized to anticipate the policies and resources that would be needed to fight the next pandemic. Believers in the plandemic scenario discussed parallels between these simulations and today’s pandemic that ranged from the concrete to the fanciful, but neither proved beyond the shadow of a doubt that COVID-19 had been planned. Then along came testimony from the chair of M-CAM, an international finance company that keeps track of patent applications.
Patent records accessed by M-CAM show that not once, but twice, U.S. drug companies colluded with government agencies to patent treatments before two disease outbreaks took place. First, between the CDC and Sequoia Pharmaceuticals for treating SARS in 2003.